FABP4 Disrupts Redox Homeostasis Through GOT2 Interaction to Drive Macrophage Mitochondrial Lipid Metabolic Reprogramming in Atherosclerosis
The FASEB Journal · 30.06.2026 · 40 (12)
DOI: 10.1096/fj.202600611r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 10.06.2026. Verfasst von Xin Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Fatty Acid-Binding Proteins, Atherosclerosis, Macrophages, Lipid Metabolism. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Hunan Provincial Nature Science Foundation Project.
Abstract (Originalsprache)
This study aims to investigate the role of fatty acid‐binding protein 4 (FABP4) in macrophage lipid metabolism and inflammatory responses during atherosclerosis development, and to determine whether its function is mediated through interaction with glutamate oxaloacetate transaminase 2 (GOT2). Herein, macrophage‐specific FABP4 knockout mice and RAW 264.7 macrophages were subjected to high‐fat diet (HFD) or oxidized LDL (ox‐LDL) treatment, respectively. Co‐immunoprecipitation (Co‐IP), qPCR, western blot, flow cytometry, ELISA, enzymatic assays, and histological staining (hematoxylin and eosin (H&E), Oil Red O) were used to assess protein interaction, expression, cytokine secretion, lipid accumulation, pro‐inflammatory activation, and redox state. Macrophage‐specific FABP4 deletion markedly reduced atherosclerotic plaque formation, lipid accumulation, pro‐inflammatory cytokine levels, and the proportion of CD86 + pro‐inflammatory macrophages, while improving systemic lipid profiles. Mechanistically, FABP4 directly bound to mitochondrial GOT2 without altering its expression, leading to disruption of mitochondrial NADH/NAD + redox homeostasis and subsequent metabolic dysfunction. Importantly, concurrent knockdown of GOT2 fully reversed the beneficial effects of FABP4 deficiency on lipid metabolism and inflammation, confirming GOT2 as a critical downstream mediator. FABP4 promotes atherosclerosis by binding to GOT2 and disrupting mitochondrial redox balance, thereby driving macrophage lipid metabolic reprogramming and inflammatory activation. Targeting the FABP4‐GOT2 axis may offer a novel therapeutic strategy for atherosclerosis and related metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, First Medical Center of Chinese PLA General Hospital, Beijing, China.
- ICU Department, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
- Institute of TCM Diagnostics, Hunan University of Chinese Medicine, Changsha, Hunan, China.
- Department of Neurosurgery, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
ORCID-Profile: Yidi Zeng
Förderung
- Hunan Provincial Nature Science Foundation Project
Zitieren
APA
Zhang, X., Yi, Q., Liang, H., Li, J., Zeng, Y., & Li, C. (2026). FABP4 Disrupts Redox Homeostasis Through GOT2 Interaction to Drive Macrophage Mitochondrial Lipid Metabolic Reprogramming in Atherosclerosis. The FASEB Journal, 40(12). https://doi.org/10.1096/fj.202600611r
Vancouver
Zhang X, Yi Q, Liang H, Li J, Zeng Y, Li C. FABP4 Disrupts Redox Homeostasis Through GOT2 Interaction to Drive Macrophage Mitochondrial Lipid Metabolic Reprogramming in Atherosclerosis. The FASEB Journal. 2026;40(12). doi:10.1096/fj.202600611r
BibTeX
@article{Zhang2026,
author = {Zhang, Xin and Yi, Qiong and Liang, Hao and Li, Jinxia and Zeng, Yidi and Li, Chunhui},
title = {FABP4 Disrupts Redox Homeostasis Through GOT2 Interaction to Drive Macrophage Mitochondrial Lipid Metabolic Reprogramming in Atherosclerosis},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {12},
doi = {10.1096/fj.202600611r}
}
EUVIMED